First Manhattan Co

SEC CIK: 0000728083
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by First Manhattan Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overview All 13F holders of NBIX Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of NBIX by First Manhattan Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−39−100.0%	Sold out	Holders
Q4 2022	39	$4.66K	<0.1%	+39	New	Holders
Q3 2021	0	$0	0.0%	−29−100.0%	Sold out	Holders
Q2 2021	29	$2.00K	<0.1%	+29	New	Holders